The prevalence of metabolic syndrome in drug-naïve bipolar II disorder patients before and after twelve week pharmacological intervention

Journal of Affective Disorders

Volumn 146, Issue 1, 2013, Pages 79-83

  Chi, Mei Hung ^a,b   Chang, Hui Hua ^c   Tzeng, Nian Sheng ^d   Huang, San Yuan ^d   Chou, Kuei Ru ^e   Tsai, Hsin Chun ^a,b   Yang, Yen Kuang ^a,c   Lu, Ru Band ^a,c   Chen, See Po ^a,b,c  

^a NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^c NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^d TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^e TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Bipolar disorder; Body mass index; Metabolic syndrome

Indexed keywords

FLUOXETINE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LORAZEPAM; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; VALPROIC ACID;

ADULT; AGED; ARTICLE; BIPOLAR II DISORDER; BLOOD PRESSURE MEASUREMENT; BODY MASS; BUTTOCK; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DRUG EFFICACY; EMOTION; FEMALE; FOLLOW UP; HAMILTON SCALE; HOMEOSTASIS; HUMAN; HYPOMANIA; INSULIN BLOOD LEVEL; MALE; METABOLIC SYNDROME X; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

ADULT; ANTIMANIC AGENTS; BIPOLAR DISORDER; BODY MASS INDEX; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; FLUOXETINE; FOLLOW-UP STUDIES; HUMANS; LORAZEPAM; MALE; METABOLIC SYNDROME X; PREVALENCE; TREATMENT OUTCOME; VALPROIC ACID; YOUNG ADULT;

EID: 84874517529     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2012.08.042     Document Type: Article

References (36)

1. M. Atmaca, M. Kuloglu, E. Tezcan, and B. Ustundag Weight gain and serum leptin levels in patients on lithium treatment Neuropsychobiology 46 2002 67 69
2. M. Atmaca, M. Kuloglu, E. Tezcan, B. Ustundag, and Y. Bayik Serum leptin and cholesterol levels in patients with bipolar disorder Neuropsychobiology 46 2002 176 179
3. D. Babic, B. Maslov, M. Martinac, K. Nikolic, S. Uzun, and O. Kozumplik Bipolar disorder and metabolic syndrome: comorbidity or side effects of treatment of bipolar disorder Psychiatria Danubina 22 2010 75 78
4. J.H. Baek, D.Y. Park, J. Choi, J.S. Kim, J.S. Choi, K. Ha, J.S. Kwon, D. Lee, and K.S. Hong Differences between bipolar I and bipolar II disorders in clinical features, comorbidity, and family history Journal of Affective Disorders 131 2011 59 67
5. M. Bauer, Y. Lecrubier, and T. Suppes Awareness of metabolic concerns in patients with bipolar disorder: a survey of European psychiatrists European Psychiatry 23 2008 169 177
6. C.L. Bowden, J.R. Calabrese, S.L. McElroy, L. Gyulai, A. Wassef, F. Petty, H.G. Pope Jr., J.C. Chou, P.E. Keck Jr., L.J. Rhodes, A.C. Swann, R.M. Hirschfeld, and P.J. Wozniak A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex maintenance study group Archives of General Psychiatry 57 2000 481 489
7. H.H. Chang, C.H. Chou, P.S. Chen, P.W. Gean, H.C. Huang, C.Y. Lin, Y.K. Yang, and R.B. Lu High prevalence of metabolic disturbances in patients with bipolar disorder in Taiwan Journal of Affective Disorders 117 2009 124 129
8. H.H. Chang, P.W. Gean, C.H. Chou, Y.K. Yang, H.C. Tsai, R.B. Lu, and P.S. Chen C825T polymorphism of the GNB3 gene on valproate-related metabolic abnormalities in bipolar disorder patients Journal of Clinical Psychopharmacology 30 2010 512 517
9. H.H. Chang, Y.K. Yang, P.W. Gean, H.C. Huang, P.S. Chen, and R.B. Lu The role of valproate in metabolic disturbances in bipolar disorder patients Journal of Affective Disorders 124 2010 319 323
10. T.T. Chang, T.L. Yeh, N.T. Chiu, P.S. Chen, H.Y. Huang, Y.K. Yang, I.H. Lee, and R.B. Lu Higher striatal dopamine transporters in euthymic patients with bipolar disorder: a SPECT study with [Tc] TRODAT-1 Bipolar Disorder 12 2010 102 106
11. P.S. Chen, Y.K. Yang, T.L. Yeh, I.H. Lee, W.J. Yao, N.T. Chiu, and R.B. Lu Correlation between body mass index and striatal dopamine transporter availability in healthy volunteers - a SPECT study Neuroimage 40 2008 275 279
12. P.S. Chen, T.L. Yeh, I.H. Lee, C.B. Lin, H.C. Tsai, K.C. Chen, N.T. Chiu, W.J. Yao, Y.K. Yang, and Y.H. Chou Effects of C825T polymorphism of the GNB3 gene on availability of dopamine transporter in healthy volunteers - a SPECT study Neuroimage 56 2011 1526 1530
13. J.L. Elmslie, R.J. Porter, P.R. Joyce, P.J. Hunt, B.I. Shand, and R.S. Scott Comparison of insulin resistance, metabolic syndrome and adiponectin in overweight bipolar patients taking sodium valproate and controls Australian and New Zealand Journal of Psychiatry 43 2009 53 60
14. A. Fagiolini, E. Frank, J.A. Scott, S. Turkin, and D.J. Kupfer Metabolic syndrome in bipolar disorder: findings from the bipolar disorder center for Pennsylvanians Bipolar Disorder 7 2005 424 430
15. J.G. Fiedorowicz, N.M. Palagummi, V.L. Forman-Hoffman, D.D. Miller, and W.G. Haynes Elevated prevalence of obesity, metabolic syndrome, and cardiovascular risk factors in bipolar disorder Annals of Clinical Psychiatry 20 2008 131 137
16. H.S. Gergerlioglu, H.A. Savas, A. Celik, E. Savas, M. Yumru, M. Tarakcioglu, N. Gergerlioglu, and M. Atmaca Atypical antipsychotic usage-related higher serum leptin levels and disabled lipid profiles in euthymic bipolar patients Neuropsychobiology 53 2006 108 112
17. N. Jabben, W.A. Nolen, J.H. Smit, S.A. Vreeburg, A.T. Beekman, and B.W. Penninx Co-occurring manic symptomatology influences HPA axis alterations in depression Journal of Psychiatric Research 45 2011 1208 1213
18. D.E. Kemp, K. Gao, P.K. Chan, S.J. Ganocy, R.L. Findling, and J.R. Calabrese Medical comorbidity in bipolar disorder: relationship between illnesses of the endocrine/metabolic system and treatment outcome Bipolar Disorder 12 2010 404 413
19. H.A. Kenna, B. Jiang, and N.L. Rasgon Reproductive and metabolic abnormalities associated with bipolar disorder and its treatment Harvard Review of Psychiatry 17 2009 138 146
20. A.M. Kilbourne, J.R. Cornelius, X.Y. Han, H.A. Pincus, M. Shad, I. Salloum, J. Conigliaro, and G.L. Haas Burden of general medical conditions among individuals with bipolar disorder Bipolar Disorder 6 2004 368 373
21. S. Markowitz, M.A. Friedman, and S.M. Arent Understanding the relation between obesity and depression: causal mechanisms and implications for treatment Clinical Psychology - Science and Practice 15 2008 1 20
22. S.L. McElroy, R. Kotwal, S. Malhotra, E.B. Nelson, P.E. Keck, and C.B. Nemeroff Are mood disorders and obesity related? A review for the mental health professional Journal of Clinical Psychiatry 65 2004 634 651 quiz 730
23. R.S. McIntyre, M. Danilewitz, S.S. Liauw, D.E. Kemp, H.T. Nguyen, L.S. Kahn, A. Kucyi, J.K. Soczynska, H.O. Woldeyohannes, A. Lachowski, B. Kim, J. Nathanson, M. Alsuwaidan, and V.H. Taylor Bipolar disorder and metabolic syndrome: an international perspective Journal of Affective Disorders 126 2010 366 387
24. R.S. McIntyre, D.A. Mancini, V.S. Basile, J. Srinivasan, and S.H. Kennedy Antipsychotic-induced weight gain: bipolar disorder and leptin Journal of Clinical Psychopharmacology 23 2003 323 327
25. R. Morriss, and F.A. Mohammed Metabolism, lifestyle and bipolar affective disorder Journal of Psychopharmacology 19 2005 94 101
26. W.T. Regenold, R.K. Thapar, C. Marano, S. Gavirneni, and P.V. Kondapavuluru Increased prevalence of type 2 diabetes mellitus among psychiatric inpatients with bipolar I affective and schizoaffective disorders independent of psychotropic drug use Journal of Affective Disorders 73 2003 301 302
27. M.F. Reynolds, E.C. Sisk, and N.L. Rasgon Valproate and neuroendocrine changes in relation to women treated for epilepsy and bipolar disorder: a review Current Medicinal Chemistry 14 2007 2799 2812
28. V. Salvi, V. D'Ambrosio, F. Bogetto, and G. Maina Metabolic syndrome in Italian patients with bipolar disorder: a 2-year follow-up study Journal of Affective Disorders 136 2012 599 603
29. A. Sicras, J. Rejas, R. Navarro, J. Serrat, and M. Blanca Metabolic syndrome in bipolar disorder: a cross-sectional assessment of a Health Management Organization database Bipolar Disorder 10 2008 607 616
30. G.E. Simon, M. Von Korff, K. Saunders, D.L. Miglioretti, P.K. Crane, G. van Belle, and R.C. Kessler Association between obesity and psychiatric disorders in the US adult population Archives of General Psychiatry 63 2006 824 830
31. N.E. Steen, P. Methlie, S. Lorentzen, S. Hope, E.A. Barrett, S. Larsson, E. Mork, B. Almas, K. Lovas, I. Agartz, I. Melle, J.P. Berg, and O.A. Andreassen Increased systemic cortisol metabolism in patients with schizophrenia and bipolar disorder: a mechanism for increased stress vulnerability? Journal of Clinical Psychiatry 72 2011 1515 1521
32. C.M. Swartz Albumin decrement in depression and cholesterol decrement in mania Journal of Affective Disorders 19 1990 173 176
33. V. Taylor, and G. MacQueen Association between bipolar disorder and metabolic syndrome: a review Journal of Clinical Psychiatry 67 2006 1034 1041
34. Y. Vinogradova, C. Coupland, J. Hippisley-Cox, S. Whyte, and C. Penny Effects of severe mental illness on survival of people with diabetes British Journal of Psychiatry 197 2010 272 277
35. N. Vogelzangs, and B.W. Penninx Depressive symptoms, cortisol, visceral fat and metabolic syndrome Tijdschrift Voor Psychiatrie 53 2011 613 620
36. M. Yumru, H.A. Savas, E. Kurt, M.C. Kaya, S. Selek, E. Savas, E.T. Oral, and I. Atagun Atypical antipsychotics related metabolic syndrome in bipolar patients Journal of Affective Disorders 98 2007 247 252